Pulmatrix (NASDAQ:PULM) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Pulmatrix (NASDAQ:PULM – Free Report) in a research report report published on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. Pulmatrix Stock Down 1.1 % Shares of NASDAQ:PULM opened at $1.96 on Thursday. The firm has a market cap of $7.15 million, a P/E ratio […]

Leave a Reply

Your email address will not be published.

Previous post Chicago Bears coach Matt Eberflus believes he set the ‘foundation’ for success. Now he awaits word on his future.
Next post Critical Survey: Agape ATP (ATPC) versus Its Peers